Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Prostate. 2015 Mar 8;75(9):1001–1008. doi: 10.1002/pros.22987

Figure 2. MSC suppression of rise in serum PSA levels during castration-resistant progression of LNCaP xenograft tumors.

Figure 2

Serum PSA levels were determined by ELISA before castration, a week after castration, and at the conclusion of the study. *, P < 0.05 from the control group. n = 5. Error bars, SEM.